Matches 1 - 50 out of 380 1 2 3 4 5 6 7 8 >


Match Document Document Title
US20100297226 MULTIPLE UNIT PHARMACEUTICAL FORMULATION  
An orally disintegratable benzimidazole formulation, featuring a plurality of compressed pellets in a MUPS tablet. The individual units feature a substrate with the active ingredient and an...
US20110150775 GENOMIC APPROACHES TO FETAL TREATMENT AND DIAGNOSIS  
The present invention provides systems for developing and/or testing therapies for prenatal diseases and conditions including Down Syndrome. The present invention also provides diagnostic methods...
US20110224723 CYANOACRYLATE TISSUE ADHESIVES  
A tissue adhesive including cyanoacrylate and polyethylene glycol (PEG), wherein the PEG remains a polyether and wherein the tissue adhesive is bioabsorbable. A tissue adhesive including...
US20130052248 ITEM OF CLOTHING FOR DAILY PHARMACOLOGICAL TREATMENT OF A FUNGAL INFECTION  
An item of clothing (10) for daily pharmacological treatment of a fungal infection, comprising: a textile material (20) to manage moisture when the item of clothing (10) is worn; microcapsules...
US20110046136 METHODS FOR THE PRODUCTION OF FUNCTIONAL PROTEIN FROM DNA HAVING A NONSENSE MUTATION AND THE TREATMENT OF DISORDERS ASSOCICATED THEREWITH  
The present invention relates to functional proteins encoded by nucleic acid sequences comprising a nonsense mutation. The present invention also relates to methods for the production of...
US20110086818 METHODS, COMPOSITIONS, AND KITS FOR TREATING PAIN AND PRURITUS  
The invention features methods, compositions, and kits for selective inhibition of pain-and itch sensing neurons (nociceptors and pruriceptors) by drug molecules of small molecule weight, while...
US20150098982 Methods and Compositions for Managing Pain Comprising Dexmedetomidine Transdermal Compositions  
Aspects of the invention include methods of managing pain in a subject by applying a transdermal delivery device containing a dexmedetomidine composition formulated to deliver a pain relieving...
US20120058199 COMPOSITIONS, USE AND METHOD FOR THE USE OF SURFACE ACTIVE PROTEINS IN TOPICAL DRUG DELIVERY ACROSS KERATIN  
The present invention provides the use of surface active proteins, especially class I and class II hydrophobins, in topically applied pharmaceutical formulations. The invention is particularly...
US20100144626 Treatment of Multi-Drug Resistant Bacterial Infections  
There is described an imidazole for the treatment of an infection caused or contributed to by microorganisms resistant to antibiotics. There is also described a method of treating a patient...
US20130202657 FOAMS OR PARTICLES FOR APPLICATIONS SUCH AS DRUG DELIVERY  
The present invention generally relates to foams and, in particular, to foams for applications such as drug delivery, and particles that are made from such foams. One aspect relates to foams or...
US20120220454 SEED COATINGS, COATING COMPOSITIONS AND METHODS FOR USE  
Coating compositions and methods of use, allowing for improved water and/or nutrient usage by seeds, plants, shrubs, and vegetation, among others, are disclosed.
US20110034522 METHODS FOR ALLEVIATING DELETERIOUS EFFECTS OF 3-DEOXYGLUCOSONE  
Disclosed is a class of compounds which inhibit the enzymatic conversion of fructose-lysine into fructose-lysine-3-phosphate in an ATP dependent reaction in a newly discovered metabolic pathway....
US20150098997 Methods and Compositions for Treating Attention Deficit Hyperactivity Disorder, Anxiety and Insomnia Using Dexmedetomidine Transdermal Compositions  
Aspects of the invention include methods of treating ADHD, anxiety or insomnia by applying a transdermal delivery device containing a dexmedetomidine composition formulated to deliver an amount of...
US20140378401 Ophthalmic Lipophilic and Hydrophilic Drug Delivery Vehicle Formulations  
The ophthalmic drug delivery vehicles provide comfort and compliance; drug solubility, residence time and permeability; and reduce side effects. In addition, the delivery vehicle can be slightly...
US20140378391 Ophthalmic Lipophilic Drug Delivery Vehicle Formulations  
The ophthalmic drug delivery vehicles provide comfort and compliance; drug solubility, residence time and permeability; and reduce side effects. In addition, the delivery vehicle can be slightly...
US20070065504 Products and methods for treating vaginal infections  
The methods of the invention treat vaginal fungal and yeast infections. More particularly, according to the methods of the invention, solid dosage forms may be administered to patients to treat...
US20150098981 Methods and Compositions for Transdermal Delivery of a Non-Sedative Amount of Dexmedetomidine  
Aspects of the invention include methods for applying to a subject a transdermal delivery device configured to deliver a non-sedative amount of a dexmedetomidine composition. In practicing methods...
US20110065766 METHODS OF USE OF ANTIVIRAL COMPOUNDS  
The present invention relates, in part, to methods of treatment, prevention, and inhibition of viral disorders. In one aspect, the present invention relates to inhibition of the M2 proton channel...
US20130338206 TOPICAL LIQUID TO AMELIORATE PAIN AND PROMOTE HEALING OF BURN-INJURED SKIN  
A novel method and composition is disclosed for treating burn injuries on human skin by promoting healing of the damaged skin. In particular, a topical liquid drug formulation is used to treat...
US20140227206 COSMETIC COMPOSITIONS CONTAINING SUBSTITUTED AZOLE AND METHODS FOR IMPROVING THE APPEARANCE OF AGING SKIN  
Methods of improving the appearance of aging skin that include applying a cosmetic composition to a target skin surface having one or more signs of aging. The cosmetic composition includes a...
US20150098983 Methods and Compositions for Treating Withdrawal Syndromes Using Non-Sedative Dexmedetomidine Transdermal Compositions  
Aspects of the invention include methods of treating withdrawal syndrome by applying a transdermal delivery device containing a dexmedetomidine composition formulated to deliver a non-sedative...
US20110076244 SURFACE COATINGS FOR SKIN  
The present invention relates to skin coating compositions and methods and, in particular, to coatings containing an active agent. In some embodiments, the coating may be applied to a skin surface...
US20060211753 METHOD AND COMPOSITION WHICH REDUCES STIMULATION OF MUSCLES WHICH DILATE THE EYE  
A method for optimizing pupil size in individuals suffering from excessive pupillary dilation in dim light as well as through medication is disclosed. Alpha 1 antagonist is applied in an eye drop...
US20130136784 METHODS FOR DELIVERY OF MEDICATION USING DISSOLVABLE DEVICES  
A method utilizing a dissolvable device for the internal delivery of medication and more particularly to the use of fibers or non-woven fabrics made of a safe polymer material incorporating a...
US20110104235 COMPOSITIONS AND METHODS FOR TREATING CONDITIONS OF THE NAIL UNIT  
The biodegradable drug delivery systems described here are formulated for implantation into the nail unit and its surrounding tissues for the treatment of various nail unit conditions. The systems...
US20110195944 MODIFIED RELEASE EMULSIONS FOR APPLICATION TO SKIN OR VAGINAL MUCOSA  
Modified release oil in water emulsions that delivers drugs to a target tissue. The emulsions according to the present invention contain the lipophilic active ingredient completely dissolved into...
US20120276182 METHODS OF TREATING FUNGAL, YEAST AND MOLD INFECTIONS  
The present invention relates to methods for treating and completely curing fungal, yeast, and/or mold infections in human subjects comprising topically administering to a human subject in need...
US20120148530 Method for the treatment or prevention of virus infection using polybiguanide-based compounds  
An inexpensive, easily available, and convenient method of treating or preventing a virus infection is provided. The present invention relates to a method for the treatment or prevention of virus...
US20150098980 Dexmedetomidine Transdermal Delivery Devices and Methods for Using the Same  
Aspects of the invention include transdermal delivery devices for delivering dexmedetomine to a subject, where the transdermal delivery devices include a single layer matrix dexmedetomine...
US20110178040 METHOD FOR TREATING FIBROSIS AND CANCER WITH IMIDAZOLIUM AND IMIDAZOLINIUM COMPOUNDS  
There is presently provided methods for delivering an anti-fibrotic or anti-cancer agent to a cell. The methods comprise contacting a cell with an effective amount of imidazolium and imidazolinium...
US20090099202 External Preparation for Athlete's Foot Treatment  
External preparations for athlete's foot treatment capable of enhancing patient's compliance and capable of reducing the symptom of rubefaction, comprising an anti-trichophyton drug mixed with at...
US20120190719 METHODS OF TREATING MOTOR DISORDERS WITH ALPHA-2B ANDRENERGIC RECEPTOR AGONISTS  
Disclosed herein is a method of treating compulsive disorders comprising administering to a subject in need of such treatment an alpha-2 receptor agonist.
US20110002877 PTEN Inhibitors Treat Neutropenia-Associated Pneumonia  
Neutropenia-associated pneumonia is treated with a therapeutically effective amount of a small-molecule PTEN inhibitor. The method may further include detecting a resultant alleviation of the...
US20120196905 SYNTHETIC COMPOUNDS AND METHODS TO DECREASE NICOTINE SELF-ADMINISTRATION  
Methods and small molecule compounds for smoking and CNS disease harm reduction are provided. One example of a class of compounds that may be used is represented by the compound having the...
US20140227208 COSMETIC COMPOSITIONS CONTAINING SUBSTITUTED AZOLE AND METHODS FOR ALLEVIATING MECHANICALLY-INDUCED SKIN INFLAMMATION  
Compositions for alleviating mechanically-induced skin inflammation, such as that caused by shaving, contain substituted azole. Methods for alleviating mechanically-induced skin inflammation...
US20110217289 Melt-Coated Dosage Forms  
Formulations of sparingly water-soluble active ingredientscomprising carrier particles provided with active ingredient-containing coatings, the sparingly soluble active ingredients being embedded...
US20140227207 COSMETIC COMPOSITIONS CONTAINING SUBSTITUTED AZOLE AND METHODS FOR ALLEVIATING THE SIGNS OF PHOTOAGED SKIN  
Cosmetic compositions for alleviating the signs of photoaged skin containing a substituted azole. Methods for alleviating the signs of photoaged skin that include applying a cosmetic composition...
US20140038974 Compositions and Methods for Eye Whitening  
The invention provides compositions and methods for whitening of eyes and/or reducing redness of eyes. The provided compositions and methods utilize low concentrations of selective α-2 adrenergic...
US20150216876 METHOD FOR TREATING INFLAMMATORY CONDITIONS  
A method for treating an autoimmune disease in a subject includes administering to the subject a therapeutically effective amount of an agent comprising an imidazole, an estrogen receptor agonist,...
US20110053913 Methods and Therapies for Alleviating Pain  
A method for alleviating or delaying onset of pain in a subject via administration of an ultra low dose of alpha-2 receptor antagonist which does not significantly block or inhibit alpha-2...
US20110300152 COMPOSITIONS AND METHODS FOR MODULATING CELL-CELL FUSION VIA INTERMEDIATE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS  
Compositions and methods are provided for modulating cell-cell fusion by using agents that modulate expression, activity, or function of intermediate-conductance calcium-activated potassium (SK4)...
US20120177585 COMPOSITIONS AND METHODS FOR TREATING PURPURA  
Embodiments of the present invention are directed to compositions and methods for the treatment of purpura. Preferred compositions comprise an α adrenergic receptor agonist selected from selective...
US20060058364 Treatment of dependence and dependence related withdrawal symptoms  
A method for treatment of dependence and dependence related withdrawal symptoms caused by the discontinuation of subacute or chronic use of psychostimulant agents, to ease a patient's withdrawal...
US20060188554 Transdermal absorption preparation  
(Object) A transdermal preparation is provided, which ensures stable and effective absorption of 4-(2-methyl-1-imidazolyl)-2,2-diphenylbutylamide (KRP-197) which has a low skin absorption and is a...
US20140134246 RAPID DISSOLVE TABLET COMPOSITIONS FOR VAGINAL ADMINISTRATION  
Disclosed herein are pharmaceutically acceptable rapid dissolve vaginal tablet compositions comprising one or more active pharmaceutical ingredients suitable for therapy via topical action or...
US20080234342 Skin Conditioning Compositions Containing Compounds for Mimicking the Effect on Skin of Retinoic Acid  
A skin care product comprising from about 0.001% to about 10% of a retinoid, in combination with 0.0001% to a bout 50% of a combination of retinoid boosters.
US20110003823 Compositions and methods for treatment of diseases and conditions associated with vasodilation and/or vascular leakage  
The invention provides compositions and methods for treating diseases and conditions, including systemic diseases and conditions, through an intravenous administration of a selective α-2...
US20070259841 Combinations for the treatment of rheumatoid arthritis  
The invention features a method for treating a patient diagnosed with rheumatoid arthritis by systemically administering an azole and a steroid to the patient. The invention also features a...
US20060019932 Treatment of rheumatoid arthritis by inhibition of pde4  
A method of treatment of rheumatoid arthritis administers an effective amount of a compound that inhibits phospho-diesterase-4.
US20140163080 Compositions and Methods for Treatment of Glaucoma  
The invention provides α-2 adrenergic receptor agonist compositions and methods for treating glaucoma and other intraocular conditions. The preferred α-2 agonist used in the inventive compositions...

Matches 1 - 50 out of 380 1 2 3 4 5 6 7 8 >